Cargando…

A promising tool: triglyceride–glucose index to stratify the risk of cardiovascular events in chronic kidney disease

Lipid profile management is one of the crucial components to optimize outcomes in patients with chronic kidney disease (CKD). CKD is associated with poor cardiovascular outcomes due to both a direct cardiovascular impact of CKD and the presence of metabolic comorbidities. Low-density lipoprotein cho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yildirim, Fatma, Yildiz, Abdullah B, Kanbay, Mehmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394708/ https://www.ncbi.nlm.nih.gov/pubmed/36003667 http://dx.doi.org/10.1093/ckj/sfac084

Ejemplares similares

Triglyceride-Glucose Index and Cardiovascular Events in Kidney Transplant Recipients
por: Colladant, Mathilde, et al.
Publicado: (2023)

Kidney replacement therapy patients with COVID-19 in the vaccine era: what do we need to know?
por: Vehbi, Sezan, et al.
Publicado: (2022)

Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
por: Quiroga, Borja, et al.
Publicado: (2022)

The assessment of hypertension in kidney transplant patients: time to change our approach?
por: Demiray, Atalay, et al.
Publicado: (2021)

Correction to: Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
Publicado: (2023)

Kidney disease and electrolytes in COVID-19: more than meets the eye
por: Carriazo, Sol, et al.
Publicado: (2020)

Increase in the global burden of chronic kidney disease: might it be attributable to air pollution?
por: Copur, Sidar, et al.
Publicado: (2022)

Visit-to-visit blood pressure variability and risk of dementia in chronic kidney disease patients: why are blood pressure changes so important in cognitive functions?
por: Yavuz, Furkan, et al.
Publicado: (2022)

Comment on Xiang et al. Association between the Triglyceride-Glucose Index and Vitamin D Status in Type 2 Diabetes Mellitus. Nutrients 2023, 15, 639
por: Mahat, Roshan Kumar, et al.
Publicado: (2023)

Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?
por: Copur, Sidar, et al.
Publicado: (2022)

Long-term effect of COVID-19 infection on hemodialysis patients: Should we follow hemodialysis patients more closely?
por: Demiray, Atalay, et al.
Publicado: (2021)

The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis
por: Li, Sangsang, et al.
Publicado: (2019)

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome
por: Wang, Le, et al.
Publicado: (2020)

The predictive value of the triglyceride—glucose index for cardiovascular events in patients with coronary chronic total occlusion
por: Li, Yingkai, et al.
Publicado: (2022)

Triglyceride-glucose index and estimated 10-year risk of a first hard cardiovascular event
por: Qu, Hua, et al.
Publicado: (2023)

Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients With Acute Coronary Syndrome
por: Guo, Qianyun, et al.
Publicado: (2022)

Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes
por: Tai, Shi, et al.
Publicado: (2022)

Risk of carotid plaques according to triglyceride-glucose index stratified by thyroid function: A cross-sectional study
por: Kim, Hye Jeong, et al.
Publicado: (2022)

Ascorbic acid: a promising agent in chronic kidney disease?
por: Karahan, Salih, et al.
Publicado: (2018)

The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
por: Barzegar, Niloofar, et al.
Publicado: (2020)

The Triglyceride-Glucose Index Can Predict Long-Term Major Adverse Cardiovascular Events in Turkish Patients With High Cardiovascular Risk
por: Hayıroğlu, Mert İlker, et al.
Publicado: (2022)

Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients
por: Alizargar, Javad, et al.
Publicado: (2020)

Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
por: Tao, Li-Chan, et al.
Publicado: (2022)

Triglyceride glucose index: A new biomarker in predicting cardiovascular risk
por: Araújo, Susilane Pereira, et al.
Publicado: (2022)

Triglyceride and Glucose Index and Sex Differences in Relation to Major Adverse Cardiovascular Events in Hypertensive Patients Without Diabetes
por: Yang, Kun, et al.
Publicado: (2021)

Higher Triglyceride–Glucose Index Is Associated With Increased Likelihood of Kidney Stones
por: Qin, Zheng, et al.
Publicado: (2021)

Promising effects of exercise on the cardiovascular, metabolic and immune system during COVID-19 period
por: Jesus, Isley, et al.
Publicado: (2020)

Comparison of the Effects of Fasting Glucose, Hemoglobin A(1c), and Triglyceride–Glucose Index on Cardiovascular Events in Type 2 Diabetes Mellitus
por: Su, Wei-Yu, et al.
Publicado: (2019)

SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

The dirty little secret of urate-lowering therapy: useless to stop chronic kidney disease progression and may increase mortality
por: Gonzalez-Martin, Guillermo, et al.
Publicado: (2020)

Triglyceride-Glucose Index is a Risk Marker of Incident COPD Events in Women
por: Zaigham, Suneela, et al.
Publicado: (2022)

Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk
por: Cai, Xiao-ling, et al.
Publicado: (2023)

Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population
por: Chen, Jiaqi, et al.
Publicado: (2023)

The Triglyceride–Glucose Index Might Be a Better Indicator for Predicting Poor Cardiovascular Outcomes in Chronic Coronary Syndrome
por: Erdoğan, Aslan, et al.
Publicado: (2023)

Triglyceride-glucose index on risk of adverse events after drug-coated balloon angioplasty
por: Lin, Zhaorong, et al.
Publicado: (2023)

Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study
por: Wu, Zhenguo, et al.
Publicado: (2022)

Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension
por: Tao, Shiyi, et al.
Publicado: (2023)

High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study
por: He, Jining, et al.
Publicado: (2023)

Triglyceride glucose index and Atherogenic index of plasma for predicting colorectal neoplasms in patients without cardiovascular diseases
por: Han, Muzhou, et al.
Publicado: (2022)

Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study
por: Li, Haibin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ou0dcdvs9hk800p17pihojn9bv